GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (CHIX:ADXNz) » Definitions » Market Cap

Addex Therapeutics (CHIX:ADXNZ) Market Cap : CHF8.88 Mil (As of May. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Addex Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Addex Therapeutics's share price for the quarter that ended in Dec. 2023 was CHF0.042. Addex Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 125.20 Mil. Therefore, Addex Therapeutics's market cap for the quarter that ended in Dec. 2023 was CHF5.26 Mil.

Addex Therapeutics's quarterly market cap declined from Jun. 2023 (CHF9.70 Mil) to Sep. 2023 (CHF6.49 Mil) and declined from Sep. 2023 (CHF6.49 Mil) to Dec. 2023 (CHF5.26 Mil).

Addex Therapeutics's annual market cap stayed the same from Dec. 2021 (CHF0.00 Mil) to Dec. 2022 (CHF0.00 Mil) but then increased from Dec. 2022 (CHF0.00 Mil) to Dec. 2023 (CHF5.26 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Addex Therapeutics's Enterprise Value for Today is CHF5.35 Mil.


Addex Therapeutics Market Cap Historical Data

The historical data trend for Addex Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Market Cap Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 5.26

Addex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 9.70 6.49 5.26

Competitive Comparison of Addex Therapeutics's Market Cap

For the Biotechnology subindustry, Addex Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Market Cap falls into.



Addex Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Addex Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=CHF0.042*125.195
=CHF5.26

Addex Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=CHF0.042*125.195
=CHF5.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Addex Therapeutics  (CHIX:ADXNz) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Addex Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (CHIX:ADXNZ) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (CHIX:ADXNZ) Headlines

No Headlines